873676-44-9

Upstream product

• 5470-84-8 4-benzyloxybutanal 

Downstream Products

• 873676-55-2 C₄₅H₅₉N₅O₁₁ 
• 873676-52-9 C₄₅H₅₉N₅O₁₁ 
• 368871-34-5 C₄₅H₆₁N₅O₁₁ 
• 368871-33-4 C₄₃H₅₈N₆O₁₀ 
• 873676-48-3 (2S,3aR,4S,6aS)-2-(3-Benzyloxy-propyl)-5-{(S)-2-cyclohexyl-2-[2-(3-hydroxy-phenyl)-acetylamino]-acetyl}-tetrahydro-[1,3]dioxolo[4,5-c]pyrrole-4-carboxylic acid methyl ester 
• 873676-49-4 (2S,3aR,4S,6aS)-5-{(S)-2-Cyclohexyl-2-[2-(3-hydroxy-phenyl)-acetylamino]-acetyl}-2-(3-hydroxy-propyl)-tetrahydro-[1,3]dioxolo[4,5-c]pyrrole-4-carboxylic acid methyl ester 
• 873676-47-2 (2S,3aR,4S,6aS)-2-(3-Benzyloxy-propyl)-5-((S)-2-tert-butoxycarbonylamino-2-cyclohexyl-acetyl)-tetrahydro-[1,3]dioxolo[4,5-c]pyrrole-4-carboxylic acid methyl ester 
• 873676-50-7 C₂₆H₃₄N₂O₇ 
• 873676-51-8 C₂₅H₃₂N₂O₇ 

Relevant academic research and scientific papers

Proline-based macrocyclic inhibitors of the hepatitis C virus: Stereoselective synthesis and biological activity

Life-saving donut: Macrocyclization through a Mitsunobu reaction was used to synthesize a 17-membered macrocycle. The bicyclic acetal core was prepared completely diastereoselectively. The macrocyclic peptidomimetic surrogate of the P2-P3 dipeptide moiety was designed to function as a hepatitis C virus (HCV) NS3 serine protease inhibitor, and the pentapeptide α-ketoamides derived from the macrocycle were shown to be potent HCV inhibitors. (Figure Presented).